Last reviewed · How we verify
NCT07169292
Effects of Wet-Cupping on Polycystic Ovary Syndrome Patients
NA trial testing Wet-cupping in Polycystic Ovarian Syndrome (PCOS) in 60 participants. Not yet recruiting.
30 June 2026
Quick facts
| Lead sponsor | Princess Nourah Bint Abdulrahman University |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 1 January 2026 |
| Primary completion | 30 June 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across Saudi Arabia |
Drugs / interventions tested
- Wet-cupping
Conditions studied
- Polycystic Ovarian Syndrome (PCOS) — all drugs for Polycystic Ovarian Syndrome (PCOS) →
Sponsor
Princess Nourah Bint Abdulrahman University
Who can join
Adults 20 to 40, female only, with Polycystic Ovarian Syndrome (PCOS). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to evaluate whether wet cupping therapy (Hijama) can improve reproductive and metabolic outcomes in women diagnosed with Polycystic Ovary Syndrome (PCOS). This study will be conducted among female participants aged 20-40 years who have been diagnosed with PCOS according to the Rotterdam criteria. The main questions it aims to answer are: Can wet cupping therapy regulate menstrual cycles in women with PCOS? Can it increase the pregnancy rate in married participants with PCOS-related infertility? Researchers will compare outcomes between a wet cupping group and a control group to determine whether Hijama has significant effects on reproductive, hormonal, and metabolic markers. Participants will: Undergo screening and eligibility evaluation using a checklist Be randomized into either the wet cupping (intervention) or control group Receive lifestyle counseling (diet and physical activity) For the intervention group: Receive one Hijama session performed by a certified practitioner Undergo follow-up at 4 and 12 weeks for clinical, hormonal, and ultrasound assessments For all participants: Complete laboratory tests, ultrasound scans, and questionnaires on PCOS symptoms and quality of life Report any side effects during and after the study period
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07169292
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Polycystic Ovarian Syndrome (PCOS)
Currently open trials in the same condition.
- NCT07392476 — Continuous Glucose Monitoring in Polycystic Ovarian Syndrome · active not recruiting
- NCT07157371 — Effects of Aerobic Exercise Training Program in Females With Insulin Resistant Polycystic Ovarian Syndrome · NA · active not recruiting
- NCT07399535 — Clinical Investigation of Herbal Formulation and Its Efficacy in Polycystic Ovarian Syndrome · Phase 1 · recruiting
Other Princess Nourah Bint Abdulrahman University trials
Trials by the same sponsor.
- NCT07464691 — Effect of Prebiotics in Saudi Adults With Type 2 Diabetes · NA · not yet recruiting
- NCT07410897 — Adapted Aquatic Exercise and Behavioral Outcomes, Flexibility, and Handgrip Strength in Children With Autism Spectrum Di · NA · completed
- NCT07270614 — Eight-week Sports Injury Prevention Program · NA · recruiting
- NCT07367607 — Circadian Modulation of Neurophysiological Responses to Therapeutic Massage Modalities · NA · completed
- NCT07308626 — Acute Effects of Reformer, Cadillac, and Chair Pilates Appa-ratuses on Cardiac Autonomic Modulation and Flexibility · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07169292 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Princess Nourah Bint Abdulrahman University
- Last refreshed: 11 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07169292.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing